bearish

YishengBio

YishengBio (依生生物) Pre-IPO: Need a Faithful Bet in PIKA

252 Views06 Apr 2021 10:54
YishengBio is a China-based biopharmaceutical company with a focus of developing PIKA based technology for vaccine and oncology. We like the concept but highlight red flags from its history.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Ke Yan, CFA, FRM
Asia Pac IPO & Placement Research, China biotech
Aequitas Research
EquitiesEquity Capital MarketsQuantitative Analysis
  • YishengBio (依生生物) Pre-IPO: Need a Faithful Bet in PIKA
    06 Apr 2021
x